Drugs Made Stock Forecast - Polynomial Regression
| DMAA Stock | 10.41 0.03 0.29% |
Drugs Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Drugs Made stock prices and determine the direction of Drugs Made In's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Drugs Made's historical fundamentals, such as revenue growth or operating cash flow patterns.
The relative strength index (RSI) of Drugs Made's stock price is about 63 suggesting that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Drugs, making its price go up or down. Momentum 63
Buy Extended
Oversold | Overbought |
Using Drugs Made hype-based prediction, you can estimate the value of Drugs Made In from the perspective of Drugs Made response to recently generated media hype and the effects of current headlines on its competitors.
The Polynomial Regression forecasted value of Drugs Made In on the next trading day is expected to be 10.43 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.41. Drugs Made after-hype prediction price | USD 10.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections. Drugs Made Additional Predictive Modules
Most predictive techniques to examine Drugs price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Drugs using various technical indicators. When you analyze Drugs charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Drugs Made Polynomial Regression Price Forecast For the 26th of January
Given 90 days horizon, the Polynomial Regression forecasted value of Drugs Made In on the next trading day is expected to be 10.43 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000069, and the sum of the absolute errors of 0.41.Please note that although there have been many attempts to predict Drugs Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Drugs Made's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Drugs Made Stock Forecast Pattern
| Backtest Drugs Made | Drugs Made Price Prediction | Buy or Sell Advice |
Drugs Made Forecasted Value
In the context of forecasting Drugs Made's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Drugs Made's downside and upside margins for the forecasting period are 10.34 and 10.52, respectively. We have considered Drugs Made's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Drugs Made stock data series using in forecasting. Note that when a statistical model is used to represent Drugs Made stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.5279 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0067 |
| MAPE | Mean absolute percentage error | 6.0E-4 |
| SAE | Sum of the absolute errors | 0.4071 |
Predictive Modules for Drugs Made
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Drugs Made In. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Drugs Made After-Hype Price Density Analysis
As far as predicting the price of Drugs Made at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Drugs Made or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Drugs Made, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Drugs Made Estimiated After-Hype Price Volatility
In the context of predicting Drugs Made's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Drugs Made's historical news coverage. Drugs Made's after-hype downside and upside margins for the prediction period are 10.32 and 10.50, respectively. We have considered Drugs Made's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Drugs Made is very steady at this time. Analysis and calculation of next after-hype price of Drugs Made In is based on 3 months time horizon.
Drugs Made Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Drugs Made is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Drugs Made backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Drugs Made, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 0.09 | 0.00 | 0.00 | 9 Events / Month | 2 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.41 | 10.41 | 0.00 |
|
Drugs Made Hype Timeline
Drugs Made In is currently traded for 10.41. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Drugs is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.01%. %. The volatility of related hype on Drugs Made is about 0.0%, with the expected price after the next announcement by competition of 10.41. About 27.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections.Drugs Made Related Hype Analysis
Having access to credible news sources related to Drugs Made's direct competition is more important than ever and may enhance your ability to predict Drugs Made's future price movements. Getting to know how Drugs Made's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Drugs Made may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SIMA | SIM Acquisition Corp | 0.00 | 8 per month | 0.13 | (0.34) | 0.28 | (0.38) | 1.42 | |
| MLAC | Mountain Lake Acquisition | 0.00 | 8 per month | 0.13 | (0.46) | 0.29 | (0.19) | 1.15 | |
| TACOU | Berto Acquisition Corp | 0.00 | 0 per month | 0.00 | (0.28) | 0.39 | (0.39) | 4.49 | |
| ALF | Centurion Acquisition Corp | 0.00 | 5 per month | 0.00 | (0.41) | 0.38 | (0.28) | 0.85 | |
| TACO | Berto Acquisition Corp | 0.00 | 7 per month | 0.00 | (0.26) | 0.30 | (0.29) | 4.06 | |
| LOKV | Live Oak Acquisition | 0.00 | 9 per month | 0.16 | (0.32) | 0.39 | (0.39) | 1.26 | |
| TACH | Titan Acquisition Corp | 0.00 | 0 per month | 0.07 | (0.31) | 0.39 | (0.39) | 1.07 | |
| OYSE | Oyster Enterprises II | 0.00 | 0 per month | 0.00 | (0.26) | 0.40 | (0.30) | 0.99 | |
| RTAC | Renatus Tactical Acquisition | 0.00 | 0 per month | 0.00 | (0.17) | 1.81 | (1.30) | 4.67 |
Other Forecasting Options for Drugs Made
For every potential investor in Drugs, whether a beginner or expert, Drugs Made's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Drugs Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Drugs. Basic forecasting techniques help filter out the noise by identifying Drugs Made's price trends.Drugs Made Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Drugs Made stock to make a market-neutral strategy. Peer analysis of Drugs Made could also be used in its relative valuation, which is a method of valuing Drugs Made by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Drugs Made Market Strength Events
Market strength indicators help investors to evaluate how Drugs Made stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Drugs Made shares will generate the highest return on investment. By undertsting and applying Drugs Made stock market strength indicators, traders can identify Drugs Made In entry and exit signals to maximize returns.
Drugs Made Risk Indicators
The analysis of Drugs Made's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Drugs Made's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting drugs stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.0679 | |||
| Standard Deviation | 0.0942 | |||
| Variance | 0.0089 | |||
| Downside Variance | 0.0194 | |||
| Semi Variance | (0.01) | |||
| Expected Short fall | (0.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Drugs Made
The number of cover stories for Drugs Made depends on current market conditions and Drugs Made's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Drugs Made is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Drugs Made's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Drugs Made Short Properties
Drugs Made's future price predictability will typically decrease when Drugs Made's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Drugs Made In often depends not only on the future outlook of the potential Drugs Made's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Drugs Made's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Percent Float | 0.0014 | |
| Shares Float | 25.2 M | |
| Short Percent | 0.0014 |
Check out Historical Fundamental Analysis of Drugs Made to cross-verify your projections. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Diversified Capital Markets space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Drugs Made. If investors know Drugs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Drugs Made In is measured differently than its book value, which is the value of Drugs that is recorded on the company's balance sheet. Investors also form their own opinion of Drugs Made's value that differs from its market value or its book value, called intrinsic value, which is Drugs Made's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Drugs Made's market value can be influenced by many factors that don't directly affect Drugs Made's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Drugs Made's value and its price as these two are different measures arrived at by different means. Investors typically determine if Drugs Made is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.